Dogan, LerzanKaya, DilaverSarikaya, TugceZengin, RehileDincer, AlpAkinci, Ibrahim OzkanAfsar, Nazire2023-02-212023-02-212020-01-0110.1016/j.bbi.2020.05.022https://hdl.handle.net/11443/981http://dx.doi.org/10.1016/j.bbi.2020.05.022Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).AutoimmuneEncephalitisCOVID-19PlasmapheresisArticleWOS:000542965400055